Louise secured a degree in Biochemistry and then went on to earn a distinction in her Master’s degree in Developmental Biology and Embryology, researching Duchenne Muscular Dystrophy as a developmental disease. Her PhD in Molecular Biology and Neuroscience at the UK Dementia Research Institute involved understanding the mechanisms behind Alzheimer’s Disease. Louise’s research then led to several publications in top peer-reviewed journals.
Passionate to explore innovation in R&D, she brings her exceptional research skills and academic rigour to the exploration of IP assets and patents for our clients. Her experience in medical writing helps her share her insights in a clear and actionable way.
Joining Source Advisors in 2024, she supports the IP services team to deliver insight and commercial value to our clients.
“Working at Source Advisors has been an exciting opportunity for me. Each day I get to use the skills and knowledge that I gained during my studies and see first-hand the difference it can make to our clients and the work they do.”
As artificial intelligence (AI) technology evolves, it is sometimes controversial as to whether new advances can be patented under existing UKIPO rules.
Every year, the European Patent Office (EPO) publishes a report that provides information on data and analysis on patent applications and granted patents across Europe
Ipsum now retired for a new state of the art UK search tool which is set to inspire innovation in the UK whilst also protecting
